The CATS-Milner Therapeutic Perspectives Series is a new panel event that provides expert opinion and thought-provoking discussion around key challenges in translational research. It is aimed at a mixed academic-industry audience and draws on expert speakers from across academia, industry, medicine, investors, policy and funding.
Our first event will focus on experimental breakthroughs and challenges in research into this neurodegenerative disease, key gaps and how to best create the right environment to support new treatments.
John Skidmore (Chief Scientific Officer, ALBORADA Drug Discovery Institute funded by Alzheimer’s Research UK)
David Rubinsztein, Cambridge Institute for Medical Research, University of Cambridge
James Rowe, MRC Cognition and Brain Sciences Unit, Dept of Clinical Neurosciences, University of Cambridge
Susan Kohlhaas (Director of Research, Alzheimer’s Research UK)
Peter Larsen (J&J Innovation)